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Abstract
Background: Exposures to ambient particulate matter (PM) are associated with increased morbidity and mortality.
PM2.5 (<2.5 μm) and ozone exposures have been shown to associate with carotid intima media thickness in
humans. Animal studies support a causal relationship between air pollution and atherosclerosis and identified
adverse PM effects on HDL functionality.
We aimed to determine whether brief exposures to PM2.5 and/or ozone could induce effects on HDL anti-oxidant
and anti-inflammatory capacity in humans.
Methods: Subjects were exposed to fine concentrated ambient fine particles (CAP) with PM2.5 targeted at
150 μg/m3, ozone targeted at 240 μg/m3 (120 ppb), PM2.5 plus ozone targeted at similar concentrations, and filtered
air (FA) for 2 h, on 4 different occasions, at least two weeks apart, in a randomized, crossover study. Blood was
obtained before exposures (baseline), 1 h after and 20 h after exposures. Plasma HDL anti-oxidant/anti-inflammatory
capacity and paraoxonase activity were determined. HDL anti-oxidant/anti-inflammatory capacity was assessed by a
cell-free fluorescent assay and expressed in units of a HDL oxidant index (HOI). Changes in HOI (ΔHOI) were
calculated as the difference in HOI from baseline to 1 h after or 20 h after exposures.
Results: There was a trend towards bigger ΔHOI between PM2.5 and FA 1 h after exposures (p = 0.18) but not 20 h
after. This trend became significant (p <0.05) when baseline HOI was lower (<1.5 or <2.0), indicating decreased HDL
anti-oxidant/anti-inflammatory capacity shortly after the exposures. There were no significant effects of ozone alone
or in combination with PM2.5 on the change in HOI at both time points. The change in HOI due to PM2.5 showed a
positive trend with particle mass concentration (p = 0.078) and significantly associated with the slope of systolic
blood pressure during exposures (p = 0.005).
Conclusions: Brief exposures to concentrated PM2.5 elicited swift effects on HDL anti-oxidant/anti-inflammatory
functionality, which could indicate a potential mechanism for how particulate air pollution induces harmful
cardiovascular effects.
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Background
Extensive epidemiological evidence demonstrates that
air pollution causes adverse health effects leading to in-
creased cardiovascular (CV) and cerebrovascular mor-
bidity and mortality, especially of ischemic nature [1, 2].
Air pollution is a heterogeneous mixture of particulate
matter (PM) and gases continuously interacting with
each other [1]. Exposure to ambient PM2.5 (PM <2.5 μm)
has been associated with the development of atheroscler-
osis [3–6] and the rate of carotid intima-media thickness
(CIMT) progression over time [7, 8]. Similarly, sub-
chronic exposure studies in animals have shown that
apolipoprotein E (ApoE) null mice exposed to PM at
ambient levels [9, 10], concentrated PM2.5 [11, 12], ultra-
fine particles (UFP) [13], and diesel exhaust emissions
[14], show accelerated atherosclerosis. ApoE null [15]
and low density lipoprotein-receptor (LDL-R) null mice
[16] exposed to intratracheal particulate, devoid of gases,
also display increased severity and complexity of athero-
sclerotic plaques. However, some studies have shown
that PM-filtered mixed vehicular and diesel exhaust
emissions induce increased inflammation in the aorta,
and altered composition of atherosclerotic plaques in
hyperlipidemic mice [17, 18]. In addition, pulmonary ex-
posure to ozone has been shown to promote vascular
dysfunction and atherogenesis in ApoE−/− mice [19], and
ambient levels of ozone have been associated with CIMT
in healthy young adults [20], suggesting that ozone could
also promote atherosclerosis. However, the mechanisms
for PM and/or ozone-induced CV toxicity are still poorly
understood and there is a lack of very much needed,
sensitive and reliable biomarkers that could help in iden-
tifying CV effects induced by air pollutants.
Risk for CV diseases is increased by a proatherogenic
lipid profile, consisting of elevated levels of low-density
lipoprotein (LDL) and triglycerides or low levels of
high–density lipoprotein cholesterol (HDL-c) [21]. A few
studies have shown that ambient air pollutant exposure
could induce modest effects on the levels of plasma
lipids [22]. Thus, LDL-R null mice exposed to re-
aerosolized ultrafine particles (UFP) displayed decreased
HDL-c [23]. However, we have shown that concentrated
ambient particles (CAPs) in the ultrafine-size range en-
hanced atherosclerotic lesions in ApoE null mice with-
out affecting HDL levels, but altering its capacity to
inhibit inflammation [13]. Likewise, both diesel exhaust
and UFP induce dysfunctional HDL that is prooxidant
and proinflammatory in ApoE null [24] and LDL-R null
mice [23].
Changes in HDL function could be as or even more
important adverse health effects than changes in quantita-
tive lipoprotein levels. HDL’s impaired cholesterol efflux
capacity is inversely correlated with CIMT and the devel-
opment of coronary artery disease (CAD), independent of
HDL-c levels [25], and subjects with acute coronary syn-
drome or ischemic cardiomyopathy displayed impaired
HDL antioxidant/anti-inflammatory function compared to
healthy controls [26, 27]. Importantly, changes in HDL
functionality could occur quite rapidly [28–30], last for a
few days in reversible disorders such as acute infections
[30] or persist for a long time, in subjects with inflamma-
tory disorders such as rheumatoid arthritis [31], systemic
lupus erythematosus [32] or CAD [26]. In the present
study, we aimed to determine whether brief 2-hour long
exposures to PM and/or ozone are capable of inducing ad-
verse changes in HDL functionality in human subjects. In
addition, we tested the notion that PM and ozone could
exert additive or synergistic effects on HDL functionality.
Results
Subject characteristics, exposures and HDL oxidant index
We studied plasma samples from subjects participating
in the Toronto component of the Clean Air Research
Center project, where the effects of PM2.5 and/or ozone
on blood pressure and vascular function have been
reported [33]. Subjects were exposed to filtered air,
concentrated PM2.5, ozone, or PM2.5 + ozone, for 2 h
(Additional file 1: Figure S1). They displayed a normal
range of lipid and glucose levels representing a healthy
cohort (Table 1). The average concentrations of PM2.5
and ozone were 149 μg/m3 and 221 μg/m3 (111 ppb), re-
spectively, in the PM2.5 and ozone individual exposures,
and 132 μg/m3 and 216 μg/m3 (109 ppb) in the com-
bined PM2.5 + ozone exposures [33] (Table 2). PM
chemical composition was rich in organic carbon and
similar in both the fine CAP and ozone aerosols (Fig. 1).
Plasma HDL anti-oxidant/anti-inflammatory capacity
was assessed by a DCF-based cell free assay, and
expressed in units of a HDL oxidant index (HOI), as
described in the Methods. This assay exhibited a high
inter-assay and inter-user reproducibility as indicated in
Table 1 Subject characteristics
Parameter Cohort (n = 30)
Demographics
Age, y 28 ± 9
Body mass index, kg/m2 23 ± 4
Sex, male/female 13/17
Blood laboratory tests
Total cholesterol, mg/dL 169 ± 28
LDL-C, mg/dL 106 ± 26
HDL-C, mg/dL 51 ± 14
Triglycerides, mg/dL 68 ± 33
Values are mean ± SD
LDL-c low density lipoprotein –cholesterol, HDL-c high
density lipoprotein-cholesterol
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previous reports [34, 35] and shown in Additional file 1:
Figure S2. Blood collection is at times accompanied with
some degree of hemolysis, which leads to release of
hemoglobin with the potential to alter redox chemistry
and interfere in our assay. The degree of hemolysis can
vary from very low, when it is imperceptible to the eye, to
gross red discoloration of the plasma. We estimated the
degree of hemolysis by spectrophotometry at a wavelength
of 410 nm, where hemoglobin shows an absorption peak
[36]. Indeed, we noted there was a significant positive as-
sociation between HOI and optimal density (OD) values
(r = 0.545, p < 0.0001, Additional file 1: Figure S3A), likely
due to the presence of higher levels of heme and redox-
active iron, which could promote redox reactions and
artifactual increase of the HOI. However, we did not ob-
serve any association when OD was < 0.6 (r = −0.024,
p = 0.649, Additional file 1: Figure S3B), suggesting
that at these levels, there was no influence on the
HOI. Therefore, we decided to exclude a total of 32
plasma samples with OD > 0.6, and circumscribe our
analyses to the 319 samples with OD <0.6. Among
these 319 study samples, HOI exhibited a non-normal
distribution, with a preponderance towards lower values
(Additional file 1: Figure S4), and it was not influenced by
age as there was no association with increasing age (r =
0.121, p = 0.524).
CAP but not ozone alters HDL antioxidant/
anti-inflammatory capacity
We evaluated the actual change in HOI (ΔHOI) as the
difference in HOI from baseline, before exposure
(Before) to 1 h after exposure (1 h after) or 20 h after ex-
posure (20 h after). Although there were no significant
differences in the mean HOI at each time point, among
the various conditions (Table 3), there was a trend




Filtered air PM2.5 Ozone PM2.5 + ozone
PM2.5, μg/m3 1.3 ± 8.0 148.5 ± 54.4 2.8 ± 11.7 132.4 ± 38.7
Ozone, μg/m3 20.8 ± 14.6 18.9 ± 11.9 221.1 ± 14.1 216.4 ± 11.9
Particle count
(≥0.3 μm)
NA 652259 ± 460843 NA 616691 ± 539005
Particle count
(≥2.0 μm)
NA 2987 ± 1918 NA 2792 ± 1963
Particle counts are average of 40 cycles, 3 min in duration, at a flow rate of
0.1 cfm. Counts are estimates upstream of the concentrator (detailed description





























Fig. 1 Particle chemical composition of (a) PM2.5 and (b) PM2.5 +
Ozone exposures. Both PM2.5 and PM2.5 + Ozone exposure aerosols
had similar particle chemical composition, which was performed as
described in Methods
Table 3 Mean HOI and PON-1 activity
Exposure Time HOI PON-1 activity
Filtered air Before 1.13 ± 0.14 0.81 ± 0.07
1 h after 1.05 ± 0.13 0.79 ± 0.08
20 h after 1.12 ± 0.18 0.72 ± 0.07
PM2.5 Before 1.04 ± 0.15 0.77 ± 0.07
1 h after 1.23 ± 0.17 0.81 ± 0.07
20 h after 1.23 ± 0.20 0.76 ± 0.07
Ozone Before 1.15 ± 0.16 0.76 ± 0.07
1 h after 1.05 ± 0.14 0.81 ± 0.09
20 h after 1.07 ± 0.18 0.78 ± 0.08
PM2.5 + ozone Before 1.15 ± 016 0.78 ± 0.07
1 h after 1.13 ± 0.14 0.83 ± 0.09
20 h after 1.21 ± 0.18 0.82 ± 0.09
Values are mean ± SEM
PON-1 activity (μmol p-nitrophenol/min/ml plasma)
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towards a bigger ΔHOI between PM2.5 and filtered air
(p = 0.18) 1 h after exposure (Fig. 2a), that was absent
20 h after (Fig. 2b) or in the ozone or PM2.5 + ozone ex-
posures, either 1 h after or 20 h after. We hypothesized
that the PM2.5 -induced effects could be stronger when
the baseline HOI was lower and subtle changes could be
better detected. Indeed, we noticed that ΔHOI induced
by PM2.5 was significantly larger, as compared with FA
exposures, when the baseline HOI was < 1.5 (p = 0.019,
Fig. 2c) or < 2.0 (p = 0.04, Fig. 2d) 1 h after exposure but
not 20 h after. Interestingly, we observed that ΔHOI 1 h
after exposure showed a positive trend with PM2.5 ex-
posure mass concentration (p = 0.078, Fig. 3). We ex-
plored whether changes in HOI were associated with
changes in PON-1 enzymatic activity, an important anti-
oxidant enzyme associated with HDL, which we have
found to be altered in hyperlipidemic mice exposed to
concentrated ultrafine particles [23] or diesel exhaust
[24]. However, we did not observe any significant differ-
ences in the enzymatic activity of PON-1 due to expo-
sures at the different time points (Table 3). Altogether,
these data suggests that PM2.5 exposure for only 2 h, in-
duced effects on HDL anti-oxidant/anti-inflammatory
function that were rather quick but resolved within 24 h
after exposure, and not associated with alteration in
PON-1 activity.
Association between ΔHOI and systolic blood pressure
PM2.5 containing exposures had been noted to increase
SBP and DBP during the 2 h exposures [33]. Therefore,
we explored whether there could be an association be-
tween effects on HOI and BP. Indeed, there was a strong
positive association between ΔHOI with the systolic BP
(SBP) slope (p = 0.005, Fig. 4a) but not diastolic BP
(DBP) slope during exposure (Fig. 4b).
Discussion
This is the first report describing significant changes
in HDL functionality induced acutely by brief expo-
sures to air pollutants in humans. We found that the
HDL anti-oxidant/anti-inflammatory capacity signifi-
cantly decreased from baseline among subjects with
lower HOI pre-exposure values, following 2 h expo-
sures to fine PM. HDL functional changes showed a
positive correlation with the PM exposure mass, and
strongly associated with elevations in systolic blood
pressure during the exposures.
We used a fluorescent assay to evaluate the HDL anti-
oxidant capacity via evaluating the ability of HDL to in-
hibit air-induced LDL oxidation, expressed as an index
(HOI). The dysfunction in HDL anti-oxidant protection
also indicates diminished HDL anti-inflammatory cap-
acity, as judged by a monocyte chemotactic assay, with a
strong correlation between both protective capacities
[24, 29]. Therefore, the HOI serves as an instrumental
measure of HDL anti-oxidant and anti-inflammatory
capacities. This assay has shown to be quite sensitive
and reproducible in previous studies [34, 35, 37] and
similar assays have been employed to demonstrate
impairment of HDL functionality in patients with
Fig. 2 Effect of PM2.5 exposure on HDL antioxidant and anti-inflammatory function. a Change in HOI from before and 1 h after exposures.
b Change in HOI from before and 20 h after exposures. c and d HOI from before and 1 h after exposures are shown in a subset where average
pre HOI is <1.5 (c) and <2.0 (d). FA = filtered air
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CAD [26, 27, 29]. We hypothesized that assessment
of HDL antioxidant protection could be affected by
small degrees of hemolysis that might occur during
processing of blood samples. We noted that HOI
strongly correlated with the degree of hemolysis,
assessed spectrophotometrically, when the OD was
equal or above 0.6 at 410 nm, but not when the OD
was less than 0.6, which is the reason why we ex-
cluded those samples from subsequent analyses. This
data suggests this could be a helpful parameter to
take into consideration when assessing HDL antioxi-
dant protection with fluorescent assays.
PM exposure has been shown to induce systemic oxi-
dative stress and atherosclerosis in various animal
models, accompanied by changes in HDL functional sta-
tus [38]. Dysfunctional HDL is emerging as a possible
marker for PM-induced early CV effects, associated with
lipid peroxidation in the blood [24]. In this context, it
could exhibit higher sensitivity than other more trad-
itional biomarkers of oxidative stress and inflammation.
For instance, we reported that ApoE null mice exposed
to ambient UFP for 5 weeks, exhibited proinflammatory
HDL and enhanced atherosclerosis [13], at the same
time when there were no significant changes in plasma
levels of IL-6 and IL-8 (unpublished). Changes in HDL
functional status could be valuable in PM-induced
CV pathogenesis as they have been associated with
the development and progression of atherosclerosis
[25–27, 29, 39]. We hypothesized that PM2.5 and
ozone exposures could lead to the development of
dysfunctional HDL in humans, with higher HOIs, in a
similar manner to diesel exhaust and ambient UFP in
Fig. 3 Association between PM2.5 mass concentration and ΔHOI.
The PM2.5 mass concentration showed a trend to associate with
ΔHOI 1 h after exposure (a) but not 20 h after exposure (b)
Fig. 4 ΔHOI associates with systolic BP slope. Change in HOI 1 h
after exposure was significantly associated with the systolic BP
change observed during the 2 h exposure (a). ΔHOI after exposure
did not correlate with diastolic BP slope (b)
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animal models of atherosclerosis [13, 23, 24]. As com-
pared with FA exposures, HOI significantly increased
after PM2.5 exposures, when baseline HOI was lower
(HOI < 1.5 or < 2.0, Fig. 2), suggesting that PM-induced ef-
fects could be more easily detected when the HDL anti-
oxidant capacity was stronger, likely indicative of a larger
antioxidant reserve. It is also plausible that among sub-
jects with HOI > 2.0, there could be pre-existing abnor-
malities in HDL function induced by any number of other
health factors that could abrogate the ability for the mod-
est impact of short-term PM2.5 exposure to be seen.
Therefore, we believe it is indeed an important observa-
tion that HOI was adversely changed among individuals
with more protective baseline HDL functionality prior to
the exposures, which accounted for 89 % of all exposures.
In addition, the change in HOI after exposure showed a
positive trend to associate with PM2.5 exposure mass con-
centration (Fig. 3). This finding adds support to the inter-
pretation of the data that PM2.5 can possibly affect HDL
function. To our knowledge, this is the first report about
the modifying effects of PM2.5 exposure on HDL function-
ality in humans. Interestingly, we have reported that
2-hour exposures to rural coarse PM (PM2.5–10) does
not induce changes in HOI or HDL-mediated choles-
terol efflux [37], which suggests the higher CV tox-
icity of urban PM2.5, as far as the ability to induce
functional changes in plasma HDL.
Ozone co-exists with PM and their interaction could
result in potentially additive harmful effects [40]. We
tested the hypothesis that a co-exposure of PM2.5 and
ozone would alter HDL function in a synergistic or addi-
tive manner but instead, neither ozone nor the combin-
ation of PM2.5 and ozone had any significant effect on
the change in HOI compared to filtered air, in the entire
study or subset of exposures with HOI <1.5 or <2.0.
Interestingly, there was no effect of ozone alone on BP
in the previous Clean Air report either, while the PM2.5
exposures caused a significant linear increase in DBP
[33]. One possibility is that CV effects due to air pollu-
tion are much stronger with the PM components than
with ozone, if at all present. Indeed, two recent meta-
analyses have shown that the incidence of myocardial in-
farctions and heart failure hospitalizations were associ-
ated with PM2.5 and PM10, but not with ozone [41, 42].
On the other hand, some controlled exposure studies
have shown that ozone potentiates the effects of PM2.5
on cardiovascular responses in humans, mice and rats.
Combined particle and ozone exposure decreased heart
rate variability in asthmatic adults [43] while ozone po-
tentiated the effect of CAPs on diastolic BP (increased)
in healthy young adults [44]. Studies on rats have shown
that ozone co-exposure potentiates the effect of PM2.5
on heart rate variability [45–47]. The fact that the
addition of ozone to fine PM blunted PM-induced
effects on HOI suggests that ozone co-exposure or other
changes in the aerosol chemical composition could have
resulted in attenuation of fine PM toxicity by mecha-
nisms not well understood [46–49]. However, while the
concentrations of sulfur dioxide and nitric oxide were
lower in the combined exposures (Table 4), it is unlikely
they could have affected particle toxicity since sulfur di-
oxide levels were too low and differences were very
small. The concentrations of nitric oxide were lower in
the combined exposures due to its reaction with ozone
to form nitrogen dioxide, which was present at higher
concentrations in the combined exposures, but without
significant differences in the concentrations of nitrogen
oxides (nitric oxide + nitrogen dioxide). In addition,
there were no differences in PM chemical composition,
including the concentrations of nitrates, sulphates,
ammonium or metals (Table 4) or any significant as-
sociations, after Bonferroni correction for multiple
comparisons, between those concentrations present in
all exposures and changes in HOI (Additional file 1:
Table S1). It is possible to consider that the addition of
ozone could have modified particle toxicity although there
was only a few seconds of reaction time for a potential
interaction between ozone and particles delivered to the
subjects. Another possibility is that the addition of ozone
could have induced alterations in the breathing pattern, by
modulation of the pulmonary autonomic response, result-
ing in decreased tidal volumes and decreased airway par-
ticle deposition. This would be consistent with our
previous report where some individuals exposed to
PM2.5 + ozone exhibited shallow breathing and reduced
IL-6 response in the blood [48]. However, we did not ob-
serve any associations between changes in HOI and re-
spiratory frequency, tidal volume or minute ventilation.
Table 4 Chemical composition of PM2.5 and PM2.5 + ozone
aerosols
Component PM2.5 PM2.5 + ozone p value
Ammonium (μg/m3) 4.7 ± 3.2 4.6 ± 4.8 0.919
Nitrate (μg/m3) 6.8 ± 6.2 5.7 ± 6.7 0.533
Sulphate (μg/m3) 11.1 ± 10.5 10.0 ± 10.9 0.693
Organic carbon (μg/m3) 28.0 ± 15.2 31.3 ± 16.5 0.425
Elemental carbon (μg/m3) 4.7 ± 3.1 4.5 ± 2.6 0.824
Total carbon (μg/m3) 32.7 ± 17.2 35.9 ± 17.4 0.488
Sulphur dioxide (μg/m3) 7.6 ± 13.6 1.9 ± 2.0* 0.03
Ozone (μg/m3) 18.9 ± 11.9 216.4 ± 11.9* 1.25 E-53
Nitric oxide (μg/m3) 23.9 ± 31.4 4.4 ± 3.5* 0.001
Nitrogen dioxide (μg/m3) 31.2 ± 19.7 48.2 ± 35.6* 0.026
Nitrogen oxide (μg/m3) 67.7 ± 53.1 54.7 ± 39.3 0.18
Total mass (μg/m3) 161.8 ± 59.7 157.7 ± 82.8 0.829
Nitrogen oxide = Nitric oxide + Nitrogen dioxide. Values are mean ± S.D. *p<0.05
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We have previously reported that an increase in HOI,
following exposure to diesel exhaust or ambient UFP in
hyperlipidemic mice was associated with a concomitant
decrease in PON-1 enzyme activity [23, 24]. However,
we did not observe any effect of pollutants on PON-1
activity in the current study. We have reported that
ApoE null mice exposed to diesel exhaust for 2 weeks
exhibited a decrease in PON-1 activity that returned
to baseline after 1 week of filtered air, even though
the HOI remained elevated, indicating that dysfunc-
tional HDL could persist as such in the presence of
normal PON-1 enzymatic activity [24]. This indicates
alternate mechanisms for the loss of HDL anti-
oxidant/anti-inflammatory function. It is possible that
PM exposures could have affected apoA1, which can
exert antioxidant effects by binding oxidized lipids, or
other antioxidant enzymes associated with HDL, such
as platelet-activating factor- acetylhydrolase (PAF-AH)
or lecithin:cholesterol acyltransferase (LCAT) [50].
LCAT activity is an important factor in HDL reverse
cholesterol transport (RCT) function, which was not
assessed in this study.
We also observed that the changes in HOI signifi-
cantly correlated with the slope of SBP during exposures
(Fig. 4). It has been reported that coarse PM exposure
mass correlates with increases in SBP and heart rate
[51], at the same time that arterial stiffness, which can
be quantified by the augmentation index (ratio of aug-
mented pressure to the pulse pressure), positively corre-
lates with SBP and dyslipidemia [52]. It is possible that
the positive association between SBP and HDL function
in our study could be due to increased PM-induced
arterial vasoconstriction. Mice fed an atherogenic diet
develop proinflammatory HDL, which can induce vaso-
constriction and impaired acetylcholine-mediated relax-
ation in mouse aortic rings [53]. In addition, HDL from
CAD patients has been shown to activate the LOX-1 re-
ceptor on endothelial cells and thus to inhibit e-NOS
dependent NO production [54]. This is the first report
on a positive association between changes in HDL func-
tion and SBP, which suggests the possibility that defect-
ive HDL could promote vasomotor dysfunction. This
could lead to altered hemodynamics and blood pressure
measures, which will need to be validated in future
studies.
HDL dysfunction is known to occur rapidly and to be
reversible [28, 30]. We observed the effects of PM 1 h
after exposure but not 20 h after. The 20-hour post-
exposure values may not be linked to PM2.5 exposure
due to diet, food and lifestyle impacts during the follow-
ing day that we could not control for, beyond the fact
that the changes may have resolved. The reversible effects
of PM on HDL function could be due to the swift onset of
oxidative stress rather than systemic inflammation, since
there were no significant changes in blood biomarkers of
inflammation in the previous Clean Air report [33].
One study limitation is that we did not evaluate other
HDL protective facets such as reverse cholesterol trans-
port. Our animals studies have shown that 2 to 10-week
exposures to air pollutants result in marked effects on
HDL antioxidant/antiinflammatory capacity that last for
a few days, but without affecting HDL-mediated choles-
terol efflux [24]. In the current study, HDL functional
changes were transient and of a short duration, which
will make it even less likely they would have involved ef-
fects on cholesterol efflux. However, identifying HDL
changes after only 2-hour exposures to concentrated
PM2.5 is quite important, even if those were of smaller
magnitude and shorter duration than those observed in
experimental animals since this suggests that brief expo-
sures to fine PM have the potential to induce harmful
vascular proinflammatory effects.
The PM2.5 levels used in this study are occupationally
relevant in firefighters, locomotive workers, garage
workers and miners [55]. Although the particle concen-
trations near highways are significantly lower in the US,
these levels can be observed for short durations of
time in many cities [33], particularly outside the US.
The ozone exposure was at 110 ppb or 0.11 ppm
(221 μg/m3) which is the maximum allowable ozone
concentration in industrial working areas [56]. We
believe that longer-term PM exposures, over several
days, are much more likely to be capable of inducing
larger and more persistent adverse effects on HDL
function. Indeed, other studies show pro-inflammatory
or endothelial dysfunction effects of PM2.5 exposures
during a few days [57], while the effects of 2-hour
controlled exposures are more modest and are more
likely due to autonomic imbalance [33].
Conclusions
In conclusion, we have found that brief PM2.5 exposures
induce acute effects on HDL anti-oxidant and anti-
inflammatory capacity, which strongly associated with
changes in systolic blood pressure during the exposures.
These findings may be important in identifying novel
biomarkers for air pollutant-mediated cardiovascular
toxicity and explaining potential mechanisms of how
PM2.5 exposures induce cardiovascular events.
Methods
Study participants, study design and exposures
The current study used stored plasma samples collected
from the Toronto component of controlled human
exposure studies performed as part of the Clean Air
research center project in Michigan and Toronto. The
study was approved by the human research ethics com-
mittee of the University of Toronto. The inclusion and
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exclusion criteria for study participants, study design
and exposure protocol have been described previously
[33]. Briefly, subjects were healthy 18- to 50-year old
non-smokers without any risk for cardiovascular disease
and were not taking any medications during the exposure
period. Subjects were pre-screened using blood biochem-
istry and were excluded when values for fasting total chol-
esterol and glucose were >240 mg/dl or >126 mg/dl
respectively. A total of 30 subjects with 13 males and 17
females participated in the study. The exposures were
conducted at the Gage controlled human inhalation facil-
ity, University of Toronto. The study design involved ran-
domized blinded exposures to four different conditions:
filtered air, concentrated fine PM (PM2.5), ozone and con-
centrated fine PM plus ozone (PM2.5 + ozone) for 2 h.
PM2.5 and ozone exposures were performed and moni-
tored as described in the parent study [33]. Briefly, ambi-
ent PM2.5 was concentrated to a target level of 150 μg/m
3
with a 2-stage Harvard virtual impactor system. PM2.5
levels were monitored during exposures by a tapered
element oscillating microbalance (Rupprecht & Patashnick
Co., Inc., model 1400a. Particle counts were obtained
using a Met One laser particle counter (Pacific Scientific
Co., model 237B). The Met One sampled the outside air
1.8 m below the concentrator inlet. Ambient particle
counts were measured in 6 size channels (0.3, 0.5, 0.7, 1.0,
2.0 and 5.0 μm) at a flow rate of 0.1 cubic feet per minute
(cfm). The Met One was run for 40 cycles of 3 min and
the average of the 40 3-min cycles was reported for
particles 0.3 μm and larger and 2.0 μm and larger. The
short 3-min sample periods were required, as longer pe-
riods would have saturated the count channels. Exposure
particle counts were not measured in the concentrated
PM2.5 air stream due to instrument limitations (negative
pressure). During exposures with PM2.5, HEPA-filtered di-
lution air (DA) was added to the ambient air upstream of
the concentrator to maintain exposure PM2.5 at the target
concentration. Particle counts were estimated upstream of
the PM2.5 concentrator using the concentrator inlet flow
rate of 1100 litres/minute and the average flow rate of
added DA, measured continuously during the exposure,
as follows: ambient particle counts x (1100 - DA)/1100, as
described previously [58]. During filtered air and ozone
exposures an in-line high efficiency particulate air filter
was inserted downstream of the concentrator, thus par-
ticle counts were zero (testing confirmed this). Ozone
(240 μg/m3 or 120 ppb) was produced by an arc generator
and added to the particle airflow. Ozone was monitored
continuously by using a Dasibi (model 1008RS) photomet-
ric analyzer. A PM2.5 filter sample was collected immedi-
ately upstream of the chamber on a 47-mm Gelman
Teflon filter with a 2 μm pore size at an air flow of
8 L/min. The sample was analyzed gravimetrically for total
mass on conditioned filters using a climate-controlled
clean room under stable conditions of 37 ± 5 % relative
humidity and 21 ± °C [58]. Ambient gases were measured
using continuous reading gas analyzers including: SO2
(Monitor Labs, model 8850); nitrogen oxides (NO, NO2,
Monitor Labs model 8840); and CO (Thermo Electron
Instruments, model 48). Readings were logged every 15 s
and averaged over the 2-hour exposure. Gases were mea-
sured after PM concentrating before delivery to the
subjects. CO, SO2, NO, NO2 were measured directly. Ni-
trogen oxides (NOX) were calculated as NO+NO2.
Each participant received all 4 exposures at least two
weeks apart. Blood pressure (BP) was determined every
30 min during the 2 h exposures. Blood was collected
before exposure (before), 1 h after exposure (1 h after)
and the following day, approximately 20 h after exposure
(20 h after). Subjects were exposed to filtered air, con-
centrated PM2.5, ozone, or PM2.5 + ozone, for 2 h, in a
blindly randomized sequence with a cross-over design
(Additional file 1: Figure S1). 28 subjects received all 4
exposures (336 blood samples), 2 subjects received 2 ex-
posures each (12 blood samples) and one subject re-
ceived an extra 5th exposure (3 blood samples), which
yielded a total of 351 stored plasma samples. Subjects
displayed a normal range of lipid and glucose levels
representing a healthy cohort (Table 1). The average
concentrations of PM2.5 and ozone in the PM2.5 only and
ozone only containing exposures were 149 ± 54 μg/m3
and 221 ± 14 μg/m3 (111 ± 7 ppb), respectively. The
particle and ozone concentrations were 132 ± 39 μg/m3
and 216 ± 12 μg/m3 (109 ppb), respectively in the co-
exposures (Table 2).
HDL anti-oxidant and anti-inflammatory capacity
HDL anti-oxidant capacity was determined as the ability
of HDL to inhibit LDL-induced oxidation of dihydrodi-
chlorofluorescein (DCFH) into the fluorescent dichlor-
ofluorescein (DCF). The assay was performed as
previously described [24, 50]. Briefly, HDL cholesterol
(HDL-c) was isolated from plasma using the dextran-
sulfate precipitation method and the HDL-c concen-
tration was determined using the Infinity cholesterol
reagent and a cholesterol standard (Thermo Scientific,
Middletown, VA). This method of HDL separation
shows the same effect on anti-oxidant capacity as HDL
obtained by ultracentrifugation [50]. The dichlorofluores-
cein diacetate (DCF-DA) (Sigma-Aldrich, St. Louis, MO)
was incubated with NaOH to induce alkaline hydrolysis of
DCF-DA to DCFH. The mixture was then neutralized
with 10X phosphate-buffered saline (PBS). Each HDL
sample was mixed with an equal concentration LDL chol-
esterol (50 μg /ml) and made up to a total volume of
100 μl with Tris–HCl buffer (pH 7.4). The mixture was
then added to a black well flat bottom microtiter plate in
triplicate and the plate was incubated at 37 °C for 1 h.
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Next, 20 μl of the DCFH reagent was added to each well
and the plate was incubated at 37 °C for 3 h. DCF fluores-
cence intensity was determined using a plate reader
(SynergyMx, BioTek, Vermont) at an excitation wave-
length of 485 nm and emission wavelength of 530 nm.
HDL anti-oxidant capacity is expressed as the HDL oxi-
dant index (HOI), determined by the ratio of DCF fluores-
cence in the presence and absence of HDL cholesterol. An
index < 1.0 denotes protective anti-oxidant HDL whereas
an index > 1.0 indicates pro-oxidant HDL. Our assay has
shown to be robust and reproducible with inter- and
intra-assay coefficient of variations of 7.30 % and 6.89 %
respectively, as previously reported [35]. This assay
has also shown a high inter-user correlation, r = 0.74,
p = 0.0003 (Additional file 1: Figure S2) [34].
Paraoxonase assay
Paraoxonase-1 (PON-1) is an HDL-associated anti-
oxidant enzyme and its activity was determined as its
ability to hydrolyze paraoxon substrate (diethyl-p-nitro-
phenyl phosphate) to p-nitrophenol, a characteristic of
only the PON-1 isoform [59]. The assay method has
been described before [24]. Briefly, 5 μl of plasma was
incubated with 2.4 mM of paraoxon substrate in 0.1 M
Tris–HCl buffer (pH 8.5) buffer containing 2 mM CaCl2
and 2.0 M NaCl at room temperature. The kinetics of
p-nitrophenol formation was determined by recording
absorbance at 405 nm every 15 s for 4 min. PON-1
enzyme activity was expressed as μmol p-nitrophenol
formed per minute for every 1 mL of plasma.
Statistical analysis
To examine the change in HOI (ΔHOI) induced by ex-
posures, the before (baseline) HOI was subtracted from
the 1 h after or 20 h after HOI in all exposures. Differ-
ences between the ΔHOI for each exposure were tested
using the Wilcoxon non-parametric test. Each subject
received all four exposures. A linear mixed effects
model, with subjects as the random effects to control for
within subject correlation of repeated measures, was
used to determine the association among ΔHOI, PM2.5
mass concentration, systolic and diastolic blood pressure
with all exposures. All tests were two-sided and a p-value
less than 0.05 was considered statistically significant. Data
were analyzed using SAS version 9.1 (SAS Institute).
Additional file
Additional file 1: Figure S1. Exposure Design. CAP, concentrated
ambient particles; BP, blood pressure. Figure adapted and modified from
[33]. Figure S2. HDL oxidant index is stable and reproducible. The
inter-user correlation is shown, r = 0.74, p = 0.0003. Figure S3. Effect
of Hemolysison HOI. Hemolysis was determined spectrophotometry at
410 nm. Increased OD readings correlated with increased HOI when
all samples were plotted (A). There was a threshold effect assamples
with OD >0.6 exhibited the association but samples with OD <0.6 did
not (B), suggesting that hemolyses did not influence HOI at these
levels. Therefore, we excluded samples with OD >0.6 from subsequent
analyses. Hemolysis did not correlate with PON-1 activity when all
samples were plotted (C). Figure S4. HOI distribution. The distribution of
HOI across the entire population of study subjects was non-normal (A).
Logarithmic transformation, however, resulted in normally distributed
data (B). Table S1. Concentration of metals in PM2.5 and PM2.5 + Ozone
exposures. (PDF 468 kb)
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